Medications for Muscular Atrophy

10 results
  • Abigale (estradiol and norethindrone acetate)

    (estradiol and norethindrone acetate)
    Xiromed LLC
    Usage: Abigale and Abigale Lo are indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, as well as the prevention of postmenopausal osteoporosis, particularly in women at significant risk. Topical products and non-estrogen medications should be considered first for certain indications.
  • Bayer HealthCare Pharmaceuticals Inc.
    Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, hypoestrogenism from hypogonadism or primary ovarian failure, and for the prevention of postmenopausal osteoporosis, with specific limitations on its use for atrophy and osteoporosis.
  • Denton Pharma, Inc. DBA Northwind Pharmaceuticals
    Usage: Estradiol tablets are indicated for treating moderate to severe menopausal symptoms, vulvar and vaginal atrophy, hypoestrogenism, breast cancer (palliative), advanced androgen-dependent prostate cancer (palliative), and for preventing osteoporosis in women at significant risk when non-estrogen therapies are inappropriate.
  • Teva Pharmaceuticals USA, Inc.
    Usage: Estradiol tablets are indicated for treating moderate to severe menopause symptoms, vulvar and vaginal atrophy, hypoestrogenism, and for palliation in breast cancer and prostate cancer. They may also be used for preventing osteoporosis in postmenopausal women at significant risk when non-estrogen options are unsuitable.
  • Denton Pharma, Inc. DBA Northwind Pharmaceuticals
    Usage: Estradiol Tablets USP are indicated for treating moderate to severe menopausal symptoms, hypoestrogenism from various causes, metastatic breast cancer (palliation), advanced androgen-dependent prostate cancer (palliation), and prevention of osteoporosis in at-risk postmenopausal women when non-estrogen options are unsuitable.
  • PD-Rx Pharmaceuticals Inc
    Usage: Estradiol tablets are indicated for treating moderate to severe menopausal vasomotor symptoms, vulvar and vaginal atrophy, hypoestrogenism, palliation of certain breast and prostate cancers, and prevention of osteoporosis in at-risk postmenopausal women. Topical products may be preferred for vaginal atrophy.
  • DIRECT RX
    Usage: Estradiol Tablets are indicated for treating moderate to severe menopausal vasomotor symptoms, vulvar and vaginal atrophy, hypoestrogenism, palliation in breast cancer and advanced prostate carcinoma, and prevention of osteoporosis in at-risk postmenopausal women when non-estrogen options are inappropriate.
  • Pfizer Laboratories Div Pfizer Inc
    Usage: ESTRING is indicated for treating moderate to severe vulvar and vaginal atrophy symptoms resulting from menopause.
  • Etyqa (estradiol and norethindrone acetate)

    (ESTRADIOL AND NORETHINDRONE ACETATE)
    Aurobindo Pharma Limited
    Usage: Etyqa is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, as well as for the prevention of postmenopausal osteoporosis in women at significant risk. Topical products are preferred for vaginal atrophy, and non-estrogen options are recommended for osteoporosis.